Diabetes Medication for Weight Loss: What Works in the UK (October 2026)

01 · The short answer

Which diabetes medicines help with weight loss?

The main medicines here are the gut-hormone injections, such as Mounjaro. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

For someone with type 2 diabetes, one medicine can address blood sugar and body weight together. For someone without diabetes, it is a weight-management treatment first. If you want the mechanism in plain language, our guide on why diabetes medication causes weight loss goes deeper.

Other medicines named in this space include semaglutide (sold as Wegovy for weight management, and as Ozempic, which is licensed for type 2 diabetes and is not a UK weight-loss medicine), and daily liraglutide (Saxenda). Wegovy pens run 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly, stepping up after at least four weeks to the 2.4mg maintenance dose from week 17.¹⁸ Liraglutide is supplied at 6mg/ml and is a daily injection, unlike once-weekly Mounjaro and Wegovy. Older oral diabetes tablets such as metformin are also discussed online, but figures vary and your prescriber can advise on them.

02 · Your decision

Is this relevant to you, and what should you do next?

It depends on whether you already have diabetes and which medicines you take.

• You have type 2 diabetes and are already treated by a GP or diabetes team. Weight loss is often a welcome effect of your treatment, but any change should be coordinated. Mounjaro is also licensed for type 2 diabetes, where it improves blood sugar control (HbA1c) and supports weight loss. If you have type 2 diabetes, treatment and monitoring are coordinated differently — tell your prescriber and your usual diabetes team so care stays joined up.¹
• You do not have diabetes but want weight-management treatment. Mounjaro is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.¹ Our guide to getting diabetes medication for weight loss explains the routes.

Anyone already taking insulin or a sulfonylurea needs extra care. Because Mounjaro slows stomach emptying, it can affect how quickly some oral medicines are absorbed, particularly when you start treatment or increase the dose. Tell your prescriber about everything you take — especially warfarin or other narrow-margin medicines, insulin, or sulfonylureas (where doses may need reducing to avoid low blood sugar). No adjustment is needed for paracetamol.¹¹³

03 · Next step

A sensible pathway from here

Start with your usual diabetes team if you are already under their care, then decide whether NHS or private treatment fits. If you choose private treatment, our weight loss clinic begins with a free online consultation reviewed by a GPhC-registered prescriber, with no obligation. Your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99), and the Mounjaro pen page shows every dose live. Every later order is £25 off the standard price.

A first-order price is not a monthly price, so plan around the standard prices. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg. Those totals are at standard price, before the new-customer and reorder discounts. Your own maintenance dose, and therefore your cost, is decided with your prescriber, not in advance.

04 · How the weight loss works

Why diabetes medication can cause weight loss

Some diabetes medicines cause weight loss because they act on the hormones that control appetite and digestion. Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. That is the real mechanism: the medicine makes eating less easier, rather than burning fat directly. It does not replace diet and activity.

This also answers a question people often ask: what causes weight loss in a diabetic person? There are two very different answers, and it matters which applies to you. Deliberate, gradual loss alongside treatment is one thing. Unexplained or rapid weight loss in someone with diabetes is another, and it should always be raised with a GP, because it can signal that blood sugar is poorly controlled. Never assume it is a good sign without checking.

The dual action is what distinguishes Mounjaro from single-action medicines such as semaglutide (Wegovy and Ozempic).¹ That does not make one right for everyone. Both are licensed treatments, and the right choice depends on your health, your other medicines and what your prescriber recommends. SURMOUNT-5 is the first large head-to-head trial of tirzepatide and semaglutide for weight loss.¹⁵

Because the medicine slows stomach emptying, side effects tend to be digestive. Common side effects include nausea, diarrhoea, vomiting, constipation and abdominal discomfort; tell your prescriber about anything new or troubling.¹³ You can also report suspected side effects through the Yellow Card scheme.¹⁹

For a fuller explanation of the biology, see how Mounjaro works for diabetes. The takeaway is simple: appetite regulation, slower digestion and better insulin response combine, and weight loss follows for many people. How much varies a great deal from person to person, which is why trial averages should be read as averages only.

05 · Mounjaro and type 2 diabetes

Mounjaro and type 2 diabetes

If you have type 2 diabetes, Mounjaro can be both a blood sugar treatment and a weight-management treatment, and your care should stay joined up. Mounjaro is also licensed for type 2 diabetes, where it improves blood sugar control (HbA1c) and supports weight loss. If you have type 2 diabetes, treatment and monitoring are coordinated differently — tell your prescriber and your usual diabetes team so care stays joined up.¹

NICE has a separate appraisal for tirzepatide in type 2 diabetes, distinct from the one covering overweight and obesity.⁸ That is worth knowing because NHS routes differ depending on whether the treatment is for diabetes control or for weight management. Your GP or diabetes nurse can tell you which applies to you locally.

The most important practical issue is your existing medicines. Because Mounjaro slows stomach emptying, it can affect how quickly some oral medicines are absorbed, particularly when you start treatment or increase the dose. Tell your prescriber about everything you take — especially warfarin or other narrow-margin medicines, insulin, or sulfonylureas (where doses may need reducing to avoid low blood sugar). No adjustment is needed for paracetamol.¹¹³

Note the wording: doses may need reducing. That is not the same as saying the medicines cannot be used together. The decision belongs to your prescriber and diabetes team, who can plan monitoring around the dose changes. Do not alter insulin or tablets on your own.

Many people with diabetes want one clear answer on which medicine is best. Honestly, there is no universal winner. The gut-hormone diabetes medication guide covers the wider class.

If you are researching prescriptions specifically, see weight loss medication prescriptions for diabetes. Whichever route you take, tell everyone involved in your care what you are taking, so your diabetes team can keep monitoring blood sugar sensibly. That joined-up approach is the single most useful habit for anyone combining diabetes treatment and weight-loss medicine.

06 · What the trial evidence shows

What the weight-loss evidence shows

The headline evidence for Mounjaro in weight management comes from the SURMOUNT-1 trial, and it is best read as an average, not a promise. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.² Trial averages do not predict your own result. Some people lose more, some less, and some stop treatment because of side effects.

The spread is also worth seeing. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.² Notice that the figures rise with the dose, which is why dose is adjusted step by step with a prescriber rather than chosen on day one.

An important caution for readers with diabetes: SURMOUNT-1 was a trial in adults with obesity or overweight. Do not assume the same average applies to you if you have type 2 diabetes. Your prescriber can set realistic expectations for your situation, and blood sugar control is a separate goal with its own measures.

Where does semaglutide fit? SURMOUNT-5, the first large head-to-head trial of tirzepatide and semaglutide for weight loss, was a separate trial from SURMOUNT-1.¹⁵ The STEP 1 trial is the semaglutide weight-management study, and it should be read on its own terms.⁹

Another common question is how much weight you can lose in the first few months. Experiences differ widely: some people notice appetite change and early loss in week one, others feel little until a higher dose — both are normal. Set expectations with your prescriber at your monthly review rather than against a headline number.

07 · NHS or private access

NHS or private: how to get treatment

You can get Mounjaro through the NHS or privately, and the right route depends on your health and how long you are willing to wait. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶

Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.⁶ The NHS guide to tirzepatide explains what the medicine is used for.⁵

So who qualifies for Mounjaro on the NHS? It depends on where the local rollout has reached and on the NICE criteria. Your GP or local integrated care board can tell you whether you are eligible now.

Why won't my doctor prescribe me Mounjaro? There are several legitimate reasons. You may not yet fall into the groups prioritised in the phased rollout. Local services may not have reached your group. Or your clinician may judge another treatment safer given your other conditions and medicines. None of that means you are being ignored; it reflects a phased programme and individual clinical judgement. Ask directly what would need to change, and when your group is expected to be reached.

For private treatment, Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.

If you have diabetes, you can use both routes sensibly: stay under your NHS diabetes team for monitoring and tell them about any private treatment. Our guide to how to get diabetes medication for weight loss walks through the options, and the weight loss injection guide for diabetes compares injectable choices.

08 · Private treatment and ordering

Ordering privately: how it works and what it costs

Ordering privately takes a free online consultation, a prescriber review and delivery, and the price shown is the price paid. EverydayMeds is a GPhC-registered UK online pharmacy (registration GPhC 9012878), and you can check us on the public register.¹²

• Free online consultation. A short health questionnaire, no charge and no obligation.
• Prescriber review. Reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Dispensing and delivery. Dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm. Delivery is free, next-day and tracked, in temperature-controlled, discreet packaging. Saturday delivery is £14.99.

We supply Mounjaro through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens, and all six doses are in stock. Needles, a sharps bin and injection guidance come with every order.

On cost, your first 2.5mg pen is £129.99 with code FIRST40 (standard price £169.99). A new customer gets £40 off their first order at any dose, including people switching to us at a higher dose. Switching at 15mg? Your first order is £289.99. After that, an automatic £25 reorder discount applies to every future order (code DOSE25). If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard price before discounts. You can see current dose prices on the Mounjaro pen page.

Across the UK pharmacies we track, the cheapest and dearest Mounjaro pen at any dose range from £143.96 to £339.00 per month, checked 11 October 2026. Payment is by Visa or Mastercard, Klarna or pay-monthly options, with no subscriptions.

Beware of counterfeit and unregulated sellers. Never buy injectable weight-loss medicine from anyone offering to supply without a consultation or prescription. Check that a pharmacy appears on the GPhC register, and see the MHRA guidance on counterfeit medicine alerts.⁷ Repeat orders re-check suitability, and there is no auto-shipping.

09 · Safety and what to tell your prescriber

Safety, side effects and what to tell your prescriber

The safest approach is full disclosure of your health history and your medicines, because that is what allows the prescriber to protect you. Mounjaro is a prescription-only medicine, supplied only after a consultation reviewed by a GPhC-registered prescriber.

What are the common side effects? The most common side effects, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort.¹³¹ Because the medicine slows how quickly the stomach empties, digestive effects are the area to watch, especially when you start and whenever the dose goes up. If something troubles you, contact your prescriber rather than waiting it out. You can also report suspected side effects through the Yellow Card scheme.¹⁹

Medicines that need particular attention are those with a narrow margin, plus insulin and sulfonylureas, where doses may need reducing to avoid low blood sugar.¹ If you take an oral contraceptive, note that the medicine can reduce its absorption because stomach emptying slows; the MHRA has published guidance on contraception with these medicines.⁷ The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹

Regulators have also reviewed mood-related reports. The European Medicines Agency's safety committee reviewed the evidence in 2024 and concluded that it does not support a causal link between GLP-1 medicines and suicidal thoughts.¹⁷ Any big change in weight, appetite and routine can affect how you feel: tell your prescriber about any history of depression, and seek help promptly if your mood drops or you have distressing thoughts during treatment.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

Is there an effect on sun sensitivity, hair or other things you may have read about? Hair loss is a listed common side effect in the patient leaflet. A change in skin sensation is listed as uncommon. Sun sensitivity is not a listed side effect in the UK patient leaflet. Discuss any new symptom with your prescriber and report it through Yellow Card.

On our service, aftercare includes ongoing monthly reviews, dose titration and follow-up assessments by the prescribing team, plus side-effect support. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413.

10 · Stopping and long-term use

What happens when you stop

Stopping a weight-loss medicine should be a planned conversation, not a sudden decision.

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.¹ In plain terms, the effects fade gradually over four to five weeks, not overnight.

As appetite regulation wears off, hunger may return. The treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them, which is why building those habits while on treatment matters most.² In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber.¹⁴

If you have diabetes, stopping has an extra dimension. Mounjaro also supports blood sugar control, so your diabetes team should know before you stop, so that monitoring and any other medicines can be reviewed. Never adjust insulin or tablets by yourself.

Dose stretching, skipping doses or other do-it-yourself plans are not something we advise. If cost or side effects are making you consider stopping, speak to your prescriber first. Any changes are made through your monthly review rather than alone. Repeat orders re-check suitability, so the prescribing team stays involved throughout.

Storage matters too: keep pens in the fridge at 2–8°C and never freeze them; once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use and must then be thrown away. Check the patient information leaflet for the full instructions.¹³

11 · Alternatives and other situations

Alternatives to Mounjaro and special situations

There are other licensed options, and the right one depends on your health, preferences and prescriber advice.

Wegovy (semaglutide). A once-weekly injection for weight management. Pens are 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, stepping up after at least four weeks to the 2.4mg maintenance dose from week 17.¹⁸ The STEP 1 trial is its main weight-management study.⁹ If you order a first Wegovy pen, check availability at the time of order; Wegovy's first-order price starts at £99.99. NHS access to Wegovy runs through specialist weight-management services; ask your GP.

Liraglutide (Saxenda). A daily injection supplied at 6mg/ml, unlike once-weekly Mounjaro and Wegovy. Figures vary — your prescriber can advise.

Tablets. Wegovy tablets and Foundayo are oral options with their own product information.²⁰²¹ No trial has compared Mounjaro directly with either tablet; current Wegovy tablet prices are shown on the product page.

Supplements. Products marketed as natural alternatives to prescription medicines, such as berberine, are low-cost supplements with no clinical oversight, and dosing is not standardised. Dramatic weight-loss claims on such products should be treated with caution, and they are not equivalent to licensed medicines.

Pre-diabetes. If your blood sugar is raised but you do not have diabetes, see medication for pre-diabetes and weight loss. The sensible first step is to speak to your GP about your results.

Insulin-dependent diabetes. If you use insulin as your main treatment, any weight-loss medicine decision needs your diabetes specialist. Safe weight loss in that situation usually means close glucose monitoring and professional guidance, because changes in food and weight can alter insulin needs. Do not start any injectable medicine without that review.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹